Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers December 3, 2016
Pharmacy Choice - News - Drug Delivery Systems - December 3, 2016

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 101     Next >>     Go To Page:

12/3/16 - Scientists develop new device to treat cancer and other ailments [Daily News Egypt]
In a recent study, scientists from The University of Texas invented a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments. Led by Lyle Hood, the study was published in the Journal of Biomedical Nanotechnology. "The problem with most drug-delivery systems is that you have a s
12/3/16 - Studies from Cornell University Reveal New Findings on Drug Delivery Systems (Concepts, technologies, and practices for drug delivery past the...
The news reporters obtained a quote from the research from Cornell University, "Limitations set by the BBB include molecule size, polarity, substrate specificity, and active efflux mechanisms. For more information on this research see: Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system
12/2/16 - Basilea expands oncology drug candidate BAL101553 clinical phase 1/2a oral study to include glioblastoma patients
Basel, Switzerland, December 02, 2016- Basilea Pharmaceutica Ltd. announced today the expansion of its ongoing oncology drug candidate BAL101553 clinical phase 1/ 2 a oral formulation study. Achim Kaufhold, Basilea's Chief Medical Officer, commented: "We are excited to explore BAL101553 in a separate glioblastoma study arm to our ongoing phase 1/
12/2/16 - Cellectar Biosciences Announces Results From the First Two Cohorts of Its CLR 131 Phase 1 Trial: Demonstrates Excellent Efficacy, Overall Survival Benefit, and Progression Free Survival Similar to or Better than Recently Approved Therapies [Seven Day
-Cellectar Biosciences, Inc., an oncology-focused, clinical stage biotechnology company, today provides a data update on the first two cohorts of the companys Phase I clinical study of CLR 131 in patients with relapsed or refractory multiple myeloma. The clinical benefit rate for this study is 80 percent despite patients receiving an average of fou
12/2/16 - China`s Luye Pharma Completes Acquistion Of Acino`s Transdermal Drug Delivery System For US$260 Million [Daily Tribune (Bahrain)]
Luye Pharma Group Ltd., a professional pharmaceutical enterprise focused on R&D and manufacture of innovative pharmaceutical products has announced the completion of its acquisition of the transdermal drug delivery systems business, Acino which is located in Zurich, Switzerland, according to a press release. The transaction saw Luye Pharma acquirin
12/2/16 - Findings from Chongqing Medical University Update Understanding of Drug Delivery Systems (Enhanced therapeutic efficacy of LHRHa-targeted brucea...
By a News Reporter-Staff News Editor at Drug Week Investigators discuss new findings in Drugs and Therapies- Drug Delivery Systems. According to news reporting originating from Chongqing, People's Republic of China, by NewsRx correspondents, research stated, "Although brucea javanica oil liposomes have been used clinically to treat ovarian cancer
12/2/16 - Findings from Shaheed Beheshti University of Medical Sciences Yields New Findings on Drug Delivery Systems (Investigating the effects of size,...
Findings from Shaheed Beheshti University of Medical Sciences Yields New Findings on Drug Delivery Systems. According to news reporting originating from Tehran, Iran, by NewsRx correspondents, research stated, "Convective flow is one of the main mechanisms of mass transfer employed in drug delivery and working in material transport in the body.
12/2/16 - GNW-News: Basilea expands oncology drug candidate BAL101553 clinical phase 1/2a oral study to include glioblastoma patients (english)
Basilea Pharmaceutica AG/ Basilea expands oncology drug candidate BAL101553 clinical phase 1/ 2 a oral study to include glioblastoma patients. Basel, Switzerland, December 02, 2016- Basilea Pharmaceutica Ltd. announced today the expansion of its ongoing oncology drug candidate BAL101553 clinical phase 1/ 2 a oral formulation study. Achim Kaufhold,.
12/2/16 - Impel NeuroPharma Announces $36M Funding to Advance Novel Drug Delivery Platform for Central Nervous System Disorders
Impel NeuroPharma received $21 M in the initial tranche with the remaining $15 M to be received upon accomplishment of certain development and business milestones. Impel NeuroPharma is developing a pipeline of drug-device combination products built upon its Precision Olfactory Delivery? nasal delivery platform. The nasal cavity is a vastly...
12/2/16 - Investigators at Stockholm University Zero in on Drug Delivery Systems (One-pot Synthesis of Metal-Organic Frameworks with Encapsulated Target...
By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies- Drug Delivery Systems have been presented. According to news reporting originating in Stockholm, Sweden, by NewsRx journalists, research stated, "Many medical and chemical applications require target molecules to be delivered in a controlled manner at precise
12/2/16 - Investigators from Purdue University Zero in on Drug Delivery Systems (Drug delivery to macrophages: Challenges and opportunities)
For more information on this research see: Drug delivery to macrophages: Challenges and opportunities. Journal of Controlled Release, 2016; 240: 202-211. Journal of Controlled Release can be contacted at: Elsevier Science Bv, PO Box 211, 1000 Ae Amsterdam, Netherlands. Our news journalists report that additional information may be obtained by conta
12/2/16 - Johns Hopkins University Assigned Patent for Methods of Manufacture and Use of Implantable Pressure-actuated Drug Delivery Systems
ALEXANDRIA, Va., Dec. 2 Johns Hopkins University, Baltimore, has been assigned a patent developed by seven co-inventors for the "methods of manufacture and use of implantable pressure-actuated drug delivery systems." The co-inventors are Chao-Wei Hwang, Ellicott City, Maryland, Hala J. Tomey, Washington, Jon R. Resar, Stevenson, Maryland, Robert
12/2/16 - Long-acting AIDS drug a step nearer to approval
China's domestically developed, long-acting experimental AIDS drug is undergoing a final review by the China Food and Drug Administration, the last stage in the approval process. "In developed countries, oral AIDS drugs are very efficient, but it's a heavy burden for patients to take medicine every day for years," says Xie Dong, chairman of Fronti
12/2/16 - Lupin receives US FDA nod for sleep disorder drug armodafinil [Seven Days (United Arab Emirates)]
The US Food and Drug Administration has granted its final approval for Lupin Ltds armodafinil tablet, which is used for treating sleep disorder. The companys US subsidiary Lupin Pharmaceuticals Inc is expected to commence promotion of this approved product, a generic version of Cephalon Incs Nuvigil tablet, in the US shortly. Nuvigil tablet had US
12/2/16 - New Biguanides Study Findings Have Been Reported from VIT University (Development of polymer-bound fast-dissolving metformin buccal film with...
New Biguanides Study Findings Have Been Reported from VIT University. According to news reporting out of Vellore, India, by NewsRx editors, research stated, "Fast-dissolving drug-delivery systems are considered advantageous over the existing conventional oral dosage forms like tablets, capsules, and syrups for being patient friendly.
12/2/16 - New Findings from Hubei University Describe Advances in Drug Delivery Systems (Preparation and Drug-Delivery Properties of Hybrid Materials...
According to news reporting originating from Wuhan, People's Republic of China, by NewsRx correspondents, research stated, "Hybrids MIL-53/GO and MIL-101/GO were synthesized and were applied for the drug delivery. For more information on this research see: Preparation and Drug-Delivery Properties of Hybrid Materials MOFs/Graphite Oxide. Science of.
12/2/16 - Patent Issued for Assembly for a Drug Delivery Device and Drug Delivery Device (USPTO 9492619)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventor Raab, Steffen, filed on February 2, 2011, was published online on November 15, 2016. The assignee for this patent, patent number 9492619, is SANOFI-AVENTIS DEUTSCHLAND GMBH. Reporters
12/2/16 - Patent Issued for Drug Delivery Device and Cartridge Holder for a Drug Delivery Device (USPTO 9492617)
By a News Reporter-Staff News Editor at Drug Week A patent by the inventors Schneider, Christiane; Stever, Tobias; Harms, Michael; Jakobi, Ulrik, filed on May 4, 2012, was published online on November 15, 2016, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9492617 is assigned to SANOFI-
12/2/16 - Reports from Institute of Physical Chemistry Add New Data to Findings in Drug Delivery Systems [Facile Construction of pH- and Redox-Responsive...
Reports from Institute of Physical Chemistry Add New Data to Findings in Drug Delivery Systems. Funders for this research include Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, Central People's Government of the People's Republic of China. Our news journalists report that addition
12/2/16 - Researchers at Harbin Institute of Technology Target Drug Delivery Systems (Multimodal Imaging-Guided Antitumor Photothermal Therapy and Drug...
According to news reporting from Harbin, People's Republic of China, by NewsRx journalists, research stated, "Elaborately designed biocompatible nanoplatforms simultaneously having diverse therapeutic and imaging functions are highly desired for biomedical applications. Financial supporters for this research include Ministry of Education of the...
12/2/16 - Researchers at Institute of Biomedical Sciences Report Findings in Drug Delivery Systems (Engineering Chimeric Receptors To Investigate the Size- and...
Researchers at Institute of Biomedical Sciences Report Findings in Drug Delivery Systems. By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies- Drug Delivery Systems have been presented. According to news originating from Taipei, Taiwan, by NewsRx correspondents, research stated, "Attachment of ligands to the sur
12/2/16 - Researchers at Institute of Physical Chemistry Report New Data on Drug Delivery Systems (Self-Assembled Smart Nanocarriers for Targeted Drug Delivery)
By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies- Drug Delivery Systems have been presented. Financial supporters for this research include National Nature Science Foundation of China, National Basic Research Program of China. Our news journalists obtained a quote from the research from the Institute of Physi
12/2/16 - Researchers at University of Ottawa Report New Data on Drug Delivery Systems (Formulation, characterization and tissue distribution of a novel...
Researchers at University of Ottawa Report New Data on Drug Delivery Systems. By a News Reporter-Staff News Editor at Drug Week Current study results on Drugs and Therapies- Drug Delivery Systems have been published. The news reporters obtained a quote from the research from the University of Ottawa, "Liposomal particles were generated using hydr
12/2/16 - Researchers from Zhejiang University Report New Studies and Findings in the Area of Drug Delivery Systems (A comparison between conventional liposome...
According to news reporting originating from Hangzhou, People's Republic of China, by NewsRx correspondents, research stated, "A drug-cyclodextrin complex in liposome system was prepared in order to make a comparison with conventional risperidone-loaded liposome. Financial support for this research came from Zhejiang university.
12/2/16 - Scientists develop new device to treat cancer and other ailments [Asian News International]
Washington D.C, Dec. 2: In a recent study, scientists from The University of Texas invented a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments. Led by Lyle Hood, the study was published in the Journal of Biomedical Nanotechnology. "The problem with most drug-delivery syst
Articles(s): 1 - 25 of 101     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415